TANG PRIZE/Drug developed by Tang Prize laureate plays role in COVID-19 treatment
11/25/2021 04:45 PM
Japanese immunologist Tadamitsu Kishimoto never expected that a drug he and his research team at Osaka University developed to treat rheumatoid arthritis (RA) would one day play a role in the fight against a global pandemic.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM
- Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM
- Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Business
Taiwan records second highest year of exports in 2024
01/09/2025 11:31 PM - Politics
Academics issue open letter opposing amended constitutional court law
01/09/2025 11:01 PM - Society
Taiwan unveils expanded carbon reduction reporting plan
01/09/2025 10:16 PM - Society
Mercury set to drop below 10°C in northern, central Taiwan on Friday
01/09/2025 10:01 PM - Society
Number of suspected INPARADISE food poisoning victims rises to 53
01/09/2025 09:30 PM